Use and positioning of fostamatinib in the management of primary chronic immune thrombocytopenia: an Italian expert opinion - Alessandro Lucchesi, Bruno Fattizzo, Valerio De Stefano, Marco Ruggeri, Sergio Siragusa, Nicola Vianelli, Francesco
![PDF] Efficacy and mechanism of intravenous immunoglobulin treatment for immune thrombocytopenia in adults | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/5c2330a7e20affaf506ba421407aa70a9a225a24/5-Figure1-1.png "PDF] Efficacy and mechanism of intravenous immunoglobulin treatment for immune thrombocytopenia in adults | Semantic Scholar")
PDF] Efficacy and mechanism of intravenous immunoglobulin treatment for immune thrombocytopenia in adults | Semantic Scholar
APS Publications on Twitter: "Platelets and tyrosine kinase inhibitors: clinical features, mechanism of action and effects on physiology - new Review in @AJPCellPhys https://t.co/G9SSGG4Hrq #platelets #articlesinpress https://t.co/oJ0JnJMjho" / Twitter
![PDF] Pathogenesis and Therapeutic Mechanisms in Immune Thrombocytopenia (ITP) | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/d711e8e86aeae763b8fc11f910a59ea4140c53c6/6-Figure1-1.png "PDF] Pathogenesis and Therapeutic Mechanisms in Immune Thrombocytopenia (ITP) | Semantic Scholar")
PDF] Pathogenesis and Therapeutic Mechanisms in Immune Thrombocytopenia (ITP) | Semantic Scholar
Clinical Pharmacokinetics and Pharmacodynamics of Fostamatinib and Its Active Moiety R406 | SpringerLink
JCM | Free Full-Text | Primary Immune Thrombocytopenia: Novel Insights into Pathophysiology and Disease Management
Evolution of CLL treatment — from chemoimmunotherapy to targeted and individualized therapy | Nature Reviews Clinical Oncology
Fostamatinib: A Review in Chronic Immune Thrombocytopenia | SpringerLink
Fostamatinib for persistent/chronic adult immune thrombocytopenia | Immunotherapy
JCM | Free Full-Text | Primary Immune Thrombocytopenia: Novel Insights into Pathophysiology and Disease Management
Novel therapies for immune thrombocytopenia - Kuter - 2022 - British Journal of Haematology - Wiley Online Library
R406 besylate | Syk inhibitor - Active metabolite of Fostamatinib | InvivoGen
Fostamatinib for persistent/chronic adult immune thrombocytopenia | Immunotherapy
Mechanism of Action | TAVALISSE HCP
Autoimmune thrombocytopenia: Current treatment options in adults with a focus on novel drugs
Medicina | Free Full-Text | Immune Thrombocytopenic Purpura as a Hemorrhagic Versus Thrombotic Disease: An Updated Insight into Pathophysiological Mechanisms
Mechanism of Action | TAVALISSE HCP
Fostamatinib - Wikipedia
Assessment of thrombotic risk during long-term treatment of immune thrombocytopenia with fostamatinib - Nichola Cooper, Ivy Altomare, Mark R. Thomas, Phillip L. R. Nicolson, Steve P. Watson, Vadim Markovtsov, Leslie K. Todd,
Rigel launches Phase II trial to assess fostamatinib for Covid-19
Favorable aspects and potential difficulties foreseen by the EP with... | Download Scientific Diagram
Advances in targeted therapy for malignant lymphoma | Signal Transduction and Targeted Therapy
Fostamatinib: a review of its clinical efficacy and safety in the management of chronic adult immune thrombocytopenia | Immunotherapy
